申请人:Hoechst Aktiengesellschaft
公开号:US06020372A1
公开(公告)日:2000-02-01
The compound of the formula I or II ##STR1## is suitable for the production of a pharmaceutical for the treatment of carcinomatous disorders, where R.sup.1 is (C.sub.3 -C.sub.5)-cycloalkyl, (C.sub.2 -C.sub.6)-alkenyl or (C.sub.2 -C.sub.6)-alkynyl, R.sup.2 is CF.sub.3, OCF.sub.3, SCF.sub.3, OH, NO.sub.2, halogen, benzyl, phenyl, CN or O-phenyl, R.sup.3 is (C.sub.1 -C.sub.4)-alkyl, halogen or a hydrogen atom and X is a --CH group or a nitrogen atom.
公式I或II的化合物##STR1##适用于制备治疗癌症性疾病的药物,其中R.sup.1是(C.sub.3-C.sub.5)-环烷基,(C.sub.2-C.sub.6)-烯基或(C.sub.2-C.sub.6)-炔基,R.sup.2是CF.sub.3,OCF.sub.3,SCF.sub.3,OH,NO.sub.2,卤素,苄基,苯基,CN或O-苯基,R.sup.3是(C.sub.1-C.sub.4)-烷基,卤素或氢原子,X是--CH基团或氮原子。